Pabi-Dexamethason Adamed Pharma (Dexamethasone)

Dexamethasone, the active ingredient in Pabi-Dexamethasone, is a corticosteroid presented as a strength/form for systemic use. It is employed to reduce inflammation and modify immune responses in a variety of acute and chronic conditions across adult and pediatric populations.

GNH USA supplies Pabi-Dexamethasone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Dexamethasone is a broad‑acting corticosteroid that modulates inflammatory and immune pathways in several disease groups. - Allergic reactions: Helps alleviate severe hypersensitivity symptoms such as airway swelling and skin edema. - Autoimmune disorders: Suppresses aberrant immune activity in conditions like systemic lupus erythematosus and rheumatoid arthritis. - Cerebral edema: Reduces intracranial pressure associated with brain tumours or postoperative swelling. - Dermatologic inflammation: Diminishes severe skin inflammation in conditions such as eczema and psoriasis. - Oncology supportive care: Mitigates chemotherapy‑induced nausea, vomiting and hypersensitivity reactions.

Dexamethasone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hyperglycemia: Elevated blood glucose levels, especially in diabetic patients. - Mood changes: Irritability, anxiety or insomnia. - Gastrointestinal discomfort: Indigestion, nausea or abdominal pain. - Fluid retention: Mild swelling of the ankles or hands. - Skin thinning: Easy bruising or delayed wound healing.

Serious or Rare Side Effects: - Severe infection: Increased susceptibility to bacterial, fungal or viral infections. - Adrenal insufficiency: Potential for life‑threatening cortisol deficiency on abrupt discontinuation. - Osteoporosis: Accelerated bone loss leading to fractures. - Psychiatric disorders: Psychosis, severe depression or mania. - Vision problems: Central serous chorioretinopathy or cataract formation.

When prescribing dexamethasone, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Infection risk: Assess for active infections before initiating therapy. - Blood glucose monitoring: Check glucose levels in diabetic or pre‑diabetic patients. - Bone health: Consider calcium and vitamin D supplementation in long‑term use. - Psychiatric assessment: Monitor mood and behavior changes. - Gastro‑intestinal protection: Use prophylactic agents if ulcer risk is high. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Dexamethasone can interact with several medicines, altering efficacy or safety profiles.

Major Interactions (Avoid): - CYP3A4 inhibitors: Strong inhibitors such as ketoconazole may increase dexamethasone plasma levels. - Live vaccines: Administration may reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely): - Anticoagulants: May enhance anticoagulant effect and raise bleeding risk.\n- Antidiabetic agents : Potential to decrease glycemic control ‑ monitor glucose. - Non‑stero­steroidal anti‑inflammatory NSAIDs : Additive risk of gastro‑intestinal bleeding. - Diuret‑t‑t ");